7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Pregnancy Complications, Hematologic D011250 11 associated lipids
Periapical Diseases D010483 4 associated lipids
Albuminuria D000419 18 associated lipids
Lymphocytosis D008218 2 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Measles D008457 3 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Acromegaly D000172 6 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Guzel S et al. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. 2013 Diab Vasc Dis Res pmid:22496403
Pichler K et al. RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. 2013 Histol. Histopathol. pmid:23553492
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Rahnama M et al. Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. 2013 J. Interferon Cytokine Res. pmid:23745763
Danks L and Takayanagi H Immunology and bone. 2013 J. Biochem. pmid:23750028
Tao H et al. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. 2013 Cardiology pmid:23751957
Rakic M et al. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. 2013 Clin Oral Implants Res pmid:22708989
Xi L et al. OPG/RANK/RANKL axis in atrial fibrillation. 2013 Cardiology pmid:23752030
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Zhu Y et al. Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. 2013 J. Cell. Physiol. pmid:22674471
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. 2013 Bone pmid:23142805
Sivagurunathan S et al. Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. 2013 J. Mol. Endocrinol. pmid:23419317
Ai LS et al. Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo. 2013 Int. J. Cancer pmid:23420490
Koide M et al. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. 2013 Endocrinology pmid:23291450
Pacifici R Osteoimmunology and its implications for transplantation. 2013 Am. J. Transplant. pmid:23915249
Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. 2013 Maturitas pmid:23916080
Panzarini SR et al. Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth. 2013 Dent Traumatol pmid:22413942
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
O'Sullivan EP et al. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. 2013 Metab. Clin. Exp. pmid:22841521
Fekete S et al. The effect of levetiracetam on rat bone mass, structure and metabolism. 2013 Epilepsy Res. pmid:24035343
He T et al. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. 2013 Int Orthop pmid:23467893
Song JF et al. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. 2013 Genet. Mol. Res. pmid:24065669
Lin C et al. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. 2013 PLoS ONE pmid:23469146
Yu F et al. Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. 2013 Endocr. J. pmid:24067544
Wu LZ et al. Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. 2013 Int. J. Mol. Med. pmid:23443505
Mazière C et al. Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. 2013 Biochem. Biophys. Res. Commun. pmid:24070606
Nishigaki M et al. β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:23452546
He JY et al. Sympathetic neuron can promote osteoblast differentiation through BMP signaling pathway. 2013 Cell. Signal. pmid:23454096
Benito-Martin A et al. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. 2013 PLoS ONE pmid:24058411
Yu J et al. Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. 2013 Biol Trace Elem Res pmid:23456427
Lau CP et al. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. 2013 Connect. Tissue Res. pmid:24060052
Corrado A et al. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. 2013 J. Rheumatol. pmid:23457386
Koluman BU et al. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. 2013 Clin. Nephrol. pmid:23458176
Wang J et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. 2013 Med. Hypotheses pmid:24074896
Kuo PL et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. 2013 Biochim. Biophys. Acta pmid:23458685
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Asanuma YF et al. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. 2013 Mod Rheumatol pmid:22584471
Sato K et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. 2013 Am. J. Pathol. pmid:23499553
Sooampon S et al. Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. 2013 J. Periodont. Res. pmid:22587561
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Galli C et al. GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. 2013 Clin Oral Implants Res pmid:22626030
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Jiang W et al. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. 2013 PLoS ONE pmid:24116163
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Gordin D et al. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. 2013 Diabetes Care pmid:23801795
Fu YX et al. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. 2013 J. Vet. Sci. pmid:23820214
Baud'huin M et al. Osteoprotegerin: multiple partners for multiple functions. 2013 Cytokine Growth Factor Rev. pmid:23827649
Wang Q et al. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. 2013 Int. Immunopharmacol. pmid:23856613
Mogi M and Kondo A The presence of RANKL-OPG complex in human osteosarcoma U2OS. 2013 J Immunoassay Immunochem pmid:23859786
Zappitelli T et al. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. 2013 J. Bone Miner. Res. pmid:23606335
Kao SY et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. 2013 Neurobiol. Dis. pmid:23607938
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Hoy J et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. 2013 J. Bone Miner. Res. pmid:23299909
Zhou J et al. [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. 2013 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:23865319
Yassuda DH et al. Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. 2013 J Biomed Mater Res A pmid:23239606
Gao L et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. 2013 J. Immunol. pmid:23241890
Brabnikova Maresova K et al. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. 2013 Calcif. Tissue Int. pmid:23247536
Eren MA et al. Association of parity with osteoprotegerin levels and atherosclerosis. 2013 Arch. Gynecol. Obstet. pmid:23287888
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Velusamy SK et al. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. 2013 J. Periodontol. pmid:23327622
Gümüş P et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. 2013 J. Periodontol. pmid:23327689
Rosenheck S The heart and the osteoclasts. 2013 Cardiology pmid:23328209
Ko GJ A biomarker, osteoprotegerin, in patients undergoing hemodialysis. 2013 Korean J. Intern. Med. pmid:24307839
Lee JE et al. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. 2013 Korean J. Intern. Med. pmid:24307842
Frederiksen L et al. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. 2013 Horm. Metab. Res. pmid:22918704
Hartwich JE et al. Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. 2013 J. Pediatr. Surg. pmid:23331792
Naidu VG et al. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. 2013 Chem. Biol. Interact. pmid:23333834
Zhang Q et al. Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. 2013 ScientificWorldJournal pmid:24222748
Yao Y et al. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. 2013 Rheumatol. Int. pmid:23334376
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Zhang F et al. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. 2013 Med. Oncol. pmid:23335067
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Guerra-Menéndez L et al. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. 2013 J Transl Med pmid:24161214
MacNee W Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. 2013 Ann. Med. pmid:23110517
Montagnana M et al. The role of osteoprotegerin in cardiovascular disease. 2013 Ann. Med. pmid:23110639
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Bosselut N et al. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. 2013 Clin. Chim. Acta pmid:23022619
Pereira AC et al. Histomorphometrical and molecular evaluation of endosseous dental implants sites in humans: correlation with clinical and radiographic aspects. 2013 Clin Oral Implants Res pmid:22092653
Tousoulis D et al. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. 2013 Int. J. Cardiol. pmid:22640692
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642

Table of Content